SOURCE-LINKED INTELLIGENCE

Protein-ligand data generation at scale to support computational hit finding and optimization

CORDIS · observation · Publication date unknown

Protein-ligand data generation at scale to support computational hit finding and optimization The ability to discover and optimize small-molecule ligands by using innovative physics-based, machine learning (ML) and artificial intelligence (AI) approaches would transform and democratize the discovery of new small molecule drugs and related research tools (chemical probes), with important implications for the development of new medicines for rare and pediatric diseases, cancer, and women’s health. The development of these methods is being held back by the lack of high-quality protein-ligand data in the public domain. To fill this gap, we have assembled a multi-sector public-private partnership that will generate high-quality, ML-ready, open protein-ligand data at scale and as a public good, and will engage with the research community to build, benchmark and test new machine learning models for small molecule discovery and optimization. Our ambition is to identify drug starting points for >500 human proteins and transform and democratize small molecule drug discovery. Chemica

Read original source ↗ Open in workspace

recordType

award

status

SIGNED

region

EU

value

29897910

unit

EUR